Prior to administration of YF-VAX vaccine, potential vaccinees or their parents or guardians should be asked about their recent health status. All potential vaccinees or their parents or guardians should be fully informed of the benefits and risks of immunization and potential for adverse events that have been temporally associated with YF-VAX vaccine administration. Vaccinees or their parents or guardians should be instructed to report all serious adverse events that occur up to 30 days post-vaccination to their health-care provider.

All travelers should seek information regarding vaccination requirements by consulting local health departments, the Centers for Disease Control and Prevention (CDC), and WHO. Travel agencies, international airlines, and/or shipping lines may also have up-to-date information. Such requirements may be strictly enforced, particularly for persons traveling from Africa or South America to Asia. Travelers should consult the latest published version of Health Information for International Travel to determine requirements and regulations for vaccination.²⁵

An International Certificate of Vaccination should be completed, signed, and validated with the center's stamp where the vaccine is administered and provided to all vaccinees. The immunization record should contain the date, lot number and manufacturer of the vaccine administered.^30-32 Subjects should be told that US vaccination certificates are valid for a period of 10 years commencing 10 days after initial vaccination or revaccination.

REFERENCES

25. CDC. Health Information for the International Traveler, 2001-2002. Atlanta:US Department of Health and Human Services, Public Health Service 2001;3-6, 12-21, 154-160, 207-220.

30. CDC. Vaccine Adverse Event Reporting System — United States. MMWR 1990;39:730-733.

31. CDC. National Childhood Vaccine Injury Act:Requirements for Permanent Vaccination Records and for Reporting of Selected Events after Vaccination. MMWR 1988;37(13):197-200.

32. Food and Drug Administration. New reporting requirements for vaccine adverse events. FDA Drug Bull 1988;18(2):16-18.

Bookmark this page: